Addiction Medicine Fellowships – Welcome to the New Era of ACGME (1.5 CME)
(1.5 CME) In this conference recording from the 2018 Annual Conference, you will learn how this year will mark the historic debut of the first addiction medicine fellowship programs to operate under the flag of the Accreditation Council for Graduate Medical Education (ACGME). As this workshop takes place, the inaugural period of ACGME application submissions will have just started, based on policies and an application form that were finalized only two months ago. This workshop, therefore, is a unique and timely opportunity to learn the latest details on what is needed to design a fellowship that can successfully join the ranks of ACGME training programs. To date, nearly 50 fellowships have been started under the auspices of The Addiction Medicine Foundation (TAMF), and many of those are now in the first round of applicants for ACGME accreditation. At least another 75-80 new fellowships must be developed and accredited by 2025 to meet the projected need for addiction medicine physicians. This workshop, therefore, is designed for those addiction medicine champions interested in leading new fellowships, as well as for those from existing TAMF-accredited programs that are preparing for the transition to ACGME.
Presenters will include four addiction medicine educators who are leaders in TAMF and the Addiction Medicine Fellowship Directors Association (AMFDA), and who are also among those now drafting ACGME applications for their own fellowships.
Utilizing an interactive format of case study demonstration and dialogue, they will guide participants in planning strategies to design programs that are feasible within their home institutions and responsive to ACGME requirements. Breakout sessions will then enable participants to work in small groups on an actual ACGME application form, with presenters circulating to assist them in designing fellowship rotations that will build knowledge and skills in the core competencies of addiction medicine. Participants will then reassemble for a guided discussion to identify promising approaches that emerged in the application exercise, as well as to find solutions to any potential barriers that were encountered. At the workshop’s conclusion, arrangements will be made with interested participants for ongoing technical assistance from TAMF and AMFDA.
Lon R. Hays
MD, MBA, DFAPA, DFASAM
Lon Roberts Hays, M.D., M.B.A. graduated from medical school at the University of Kentucky in 1982 then pursued residency training at the University of Kentucky, which he completed in 1986. At that time he joined the faculty in the Department of Psychiatry where he has served as Chair from 1998 to 2018, and is director of the Addiction Medicine Fellowship. In addition to being Board Certified by the American Board of Psychiatry and Neurology, Dr. Hays also is certified by the American Board of Addiction Medicine and has Added Qualifications in both Addiction Psychiatry and Geriatric Psychiatry. He completed a Certificate of Medical Management in 1998 and went on to obtain his M.B.A. from the University of Kentucky Gatton School of Business in May 2001. Dr. Hays is a Co-investigator on numerous grants involving drugs of abuse. He is the Director of Area V of the American Academy of Addiction Psychiatry, President of the Addiction MedicineFoundation, a Distinguished Fellow of the American Psychiatric Association, and an elected member and Fellow of the American College of Psychiatrists."
MD, PhD, DFASAM
Dr. Brown is on the Board of Directors of The Addiction Medicine Foundation and is President-Elect of the Addiction Medicine Fellowship Directors Association. He is Board Certified in Family Medicine and Addiction Medicine. He has been heavily involved in fellowship development at the program for which he was the founding Director at the University of Wisconsin School of Medicine and Public Health, as well as at the national level. He serves as a consulting physician in addiction medicine at UW Hospital (where he is the Director of the Center for Addictive Disorders), William S. Middleton Memorial Veterans Hospital, the UW Hospital HIV/AIDS Clinic, and at Access Community Health Centers (a network of Federally Qualified Health Centers). Dr. Brown is also the Director of the UW SMPH fourth year Clinical Addiction Elective, and the Medical Director of the Overdose Prevention Program of the AIDS Resource Center of Wisconsin. Dr. Brown holds a PhD in Population Health Sciences from the University of Wisconsin.
Timothy K. Brennan
MD, MPH, FASAM
Timothy Brennan, MD, MPH, FASAM is an Addiction Medicine physician and Pediatrician. He is the Director of the Addiction Institute at Mount Sinai West and St. Luke's Hospitals in New York City and the Vice President for Medical and Academic Affairs at The Addiction Medicine Foundation. He is also the Director of the Fellowship in Addiction Medicine at the Icahn School of Medicine at Mount Sinai. He completed a Fellowship in Addiction Medicine at the Addiction Institute of New York, a Fellowship in Medical Ethics at Harvard Medical School, a Residency in Pediatrics at Weill Cornell Medical College / New York Presbyterian Hospital, and an Internship in Internal Medicine at Georgetown University Hospital. He is the Co-Editor of Essentials of Addiction Medicine and Board Certified in Addiction Medicine and Pediatrics.
Jeanette M. Tetrault
MD, FACP, FASAM
Dr. Tetrault’s scholarly work focuses on care of patients with addicition and the medical co-morbidities associated with substance use, mainly HIV and Hepatitis C. She is a diplomate of the American Board of Addiction Medicine. Dr. Tetrault is a physician providing primary care and buprenorphine/naloxone treatment at the Central Medical Unit of the APT Foundation, a multi-specialty addiction treatment facility, and is an attending physician at Yale New Haven Hospital (YNHH). She is the co-director of the Addiction Recovery Clinic in the Adult Primary Care Clinic at the St. Raphael's Campus of YNHH, which serves both a clinical care and a teaching mission. She was selected as a Macy Foundation Faculty Scholar in 2017. She is the Program Director for the Yale Addiction Medicine Fellowship Program and serves on the Board of Directors for The Addiction Medicine Foundation and the Addiction Medicine Fellowship Directors Association. She is a past-president of the New England Region of SGIM and co-chair of the Alcohol, Tobacco and Other Drug Use Interest Group for SGIM.
ACCME Accreditation Statement
The American Society of Addiction Medicine is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians.
AMA Credit Designation Statement
The American Society of Addiction Medicine designates this enduring material for a maximum of 1.5 AMA PRA Category 1 Credit(s)™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
ABPM Maintenance of Certification (MOC)
The American Board of Preventive Medicine (ABPM) has approved this activity for a maximum of 1.5 LLSA credits towards ABPM MOC Part II requirements.
ABAM Transitional Maintenance of Certification (tMOC)
This course has been approved by the American Board of Addiction Medicine (ABAM). Physicians enrolled in the ABAM Transitional Maintenance of Certification Program (tMOC) can apply a maximum of 1.5 AMA PRA Category 1 Credit(s)™ for completing this course.